Revvity Inc. (NYSE:RVTY - Get Free Report)'s stock price crossed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $150.85 and traded as low as $147.18. Revvity shares last traded at $148.6560, with a volume of 1,480,353 shares traded.
Wall Street Analyst Weigh In
RVTY has been the topic of several recent analyst reports. UBS Group assumed coverage on shares of Revvity in a report on Wednesday, September 9th. They issued a "neutral" rating and a $140.00 price target on the stock. Evercore reissued an "outperform" rating on shares of Revvity in a report on Wednesday, August 5th. Barclays boosted their target price on shares of Revvity from $160.00 to $175.00 and gave the stock an "equal weight" rating in a research report on Wednesday, November 4th. Sanford C. Bernstein restated a "market perform" rating on shares of Revvity in a research note on Thursday. Finally, Cfra upgraded shares of Revvity from a "hold" rating to a "buy" rating in a research note on Wednesday, November 4th. Six investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to data from MarketBeat, Revvity currently has an average rating of "Hold" and an average price target of $136.71.
Check Out Our Latest Stock Report on RVTY
Revvity Price Performance
The company has a market capitalization of $16.60 billion, a P/E ratio of 65.78, a price-to-earnings-growth ratio of 2.75 and a beta of 1.08. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.65 and a quick ratio of 2.10. The company has a fifty day moving average price of $150.85 and a 200 day moving average price of $114.48.
Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.38 earnings per share for the quarter, topping analysts' consensus estimates of $1.30 by $0.08. The business had revenue of $728.90 million for the quarter, compared to analysts' expectations of $694.73 million. Revvity had a net margin of 8.61% and a return on equity of 8.64%. The company's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.18 EPS. On average, sell-side analysts forecast that Revvity Inc. will post 5.42 EPS for the current fiscal year.
Revvity Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 12th. Shareholders of record on Friday, January 22nd will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 22nd. Revvity's payout ratio is presently 12.39%.
Insider Activity
In other Revvity news, insider Tajinder Vohra sold 7,330 shares of the company's stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the transaction, the insider owned 6,635 shares in the company, valued at approximately $934,738.80. This represents a 52.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Maxwell Krakowiak sold 1,631 shares of the firm's stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $144.53, for a total transaction of $235,728.43. Following the completion of the sale, the insider owned 14,781 shares in the company, valued at $2,136,297.93. The trade was a 9.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 9,045 shares of company stock valued at $1,281,439. 0.85% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Durable Capital Partners LP bought a new stake in shares of Revvity in the 3rd quarter worth approximately $201,890,000. Toronto Dominion Bank boosted its holdings in Revvity by 3.2% during the third quarter. Toronto Dominion Bank now owns 19,210 shares of the company's stock worth $2,937,000 after buying an additional 588 shares in the last quarter. State of Tennessee Department of Treasury boosted its holdings in Revvity by 154.1% during the third quarter. State of Tennessee Department of Treasury now owns 35,434 shares of the company's stock worth $5,418,000 after buying an additional 21,489 shares in the last quarter. Cetera Investment Advisers boosted its holdings in Revvity by 4.1% during the third quarter. Cetera Investment Advisers now owns 18,810 shares of the company's stock worth $2,876,000 after buying an additional 747 shares in the last quarter. Finally, Empirical Finance LLC acquired a new position in Revvity in the third quarter worth approximately $683,000. 86.65% of the stock is currently owned by institutional investors.
Revvity Company Profile
(
Get Free Report)
Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company's work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.